Search - tctmd.com

Displaying 221 - 240 of 2624

Sort: Relevancy | Date

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Updates From the UK All-Comer TAVR Study

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

Is Subclavian-Axillary TAVR the Preferred Alternative?

Presenter: A. Pieter Kappetein

June 16, 2016

Presentation TVT 2016

Updates From SURTAVI in Intermediate-Risk Patients

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Advantages and Technique Recommendations for Direct Aortic Access for TAVR

Presenter: Vinayak Bapat

June 16, 2016

Presentation TVT 2016

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Presenter: Vinod H. Thourani

June 16, 2016

Presentation TVT 2016

Transapical TAVR Remains a Worthwhile and Necessary Alternative: Results in a High-Volume Center and Optimal Technique

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

Updates From NOTION: The First All-Comer TAVR Trial

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

TVT 1075: Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?

Presenter: Ashkan Karimi, MD

June 16, 2016

Presentation TVT 2016

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Presenter: James M. McCabe

June 16, 2016

Presentation TVT 2016

TVT 1125: Aortic Annulus Pseudoaneurysm Following Transcatheter Aortic Valve Implantation A Multimodality Approach to Define the Best Therapeutic Alternative

Presenter: Rogerio Sarmento-Leite, MD

June 16, 2016

Presentation TVT 2016

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Presenter: Jonathon M. White

June 16, 2016

Presentation TVT 2016

Highlights From PARTNER 2A in Intermediate-Risk Patients

Presenter: Michael J. Mack

June 16, 2016

Presentation TVT 2016

TVT 1074: Left Main Obstruction During TAVR With Lotus Valve

Presenter: Marek Grygier, MD

June 16, 2016

Presentation TVT 2016

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

Presenter: Antonio Colombo

June 16, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

A Practical Guide for the Treatment of Paravavular Regurgitation After TAVR

Presenter: Torsten P. Vahl

June 16, 2016

Presentation TVT 2016

TVT 1079: What Is This New Jet?! Acquired AortoRight Ventricular Fistula After Sapien 3 TAVR

Presenter: Hasan Ahmad, MD

June 16, 2016

Presentation TVT 2016

Multimodality Intraprocedural Assessment of the Severity of Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

June 16, 2016

Presentation TVT 2016

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

Presenter: Bernard Prendergast

June 16, 2016

Advertisement

Study Design for the EVOLUT R Low-Risk Trial

Updates From the UK All-Comer TAVR Study

Is Subclavian-Axillary TAVR the Preferred Alternative?

Updates From SURTAVI in Intermediate-Risk Patients

Advantages and Technique Recommendations for Direct Aortic Access for TAVR

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Transapical TAVR Remains a Worthwhile and Necessary Alternative: Results in a High-Volume Center and Optimal Technique

Updates From NOTION: The First All-Comer TAVR Trial

TVT 1075: Late Paravalvular Aortic Regurgitation: Migration of the Valve or Late Recoil?

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

TVT 1125: Aortic Annulus Pseudoaneurysm Following Transcatheter Aortic Valve Implantation A Multimodality Approach to Define the Best Therapeutic Alternative

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Highlights From PARTNER 2A in Intermediate-Risk Patients

TVT 1074: Left Main Obstruction During TAVR With Lotus Valve

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

A Practical Guide for the Treatment of Paravavular Regurgitation After TAVR

TVT 1079: What Is This New Jet?! Acquired AortoRight Ventricular Fistula After Sapien 3 TAVR

Multimodality Intraprocedural Assessment of the Severity of Paravalvular Regurgitation After TAVR

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content